Holy Basil for sensitive skin linked to stress
Official title: OBSERVATIONAL STUDY OF THE EFFICACY ON SENSITIVE SKIN OF AN ORAL FORMULATION BASED ON PURPLE BASIL, FOR 8 WEEKS IN 2 GROUPS OF 100 VOLUNTEERS
Run by Laboratoires Expanscience S.A. · NCT07811310 · Data updated 2026-11-12
This study tests whether a holy basil extract can help women aged 45–65 with stress-related sensitive skin compare to a placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 65 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Laboratoires Expanscience S.A. Industry-sponsored |
| Locations | 1 site (Valencia, Valencia) |
| Status | Recruiting |
| Started | August 31, 2026 |
| Main results expected | November 18, 2026 |
| Study ends | November 18, 2026 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT07811310 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 45–65 with stress-related sensitive skin and a perceived link between stress and their skin symptoms.
✕Probably not a fit
Individuals without stress-related skin sensitivity or those with conditions listed in the exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates the effects of holy basil extract on skin sensitivity in women aged 45 to 65 who report stress and a link between stress and their skin symptoms. Participants receive either holy basil extract or placebo and are monitored for changes in skin tightness, malaise, and related symptoms. The trial excludes individuals with certain medical conditions or recent skin studies to reduce confounding factors. The sponsor seeks to determine if the plant extract can improve barrier-related symptoms associated with stress. The study context includes a company collaboration and a single-site location in Valencia, Spain.
Why it matters
Potential benefit: If successful, participants may experience reduced skin sensitivity and related discomfort linked to stress.
How similar studies have gone: Other studies in the field have explored botanical extracts for skin symptoms, with mixed results; this trial tests a specific holy basil extract.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gender: Women * People aged between 45 and 65 years. * Presenting sensitive skin (Sensitive Scale 10 ≥ 20) with Tightness ≥ 4 and general malaise ≥ 4. * People who report being stressed (PSS10 questionnaire ≥ 14) and who report a relationship between skin sensitivity and psychological stress (according to the volunteer's opinion). * Last participation in a clinical study on the face, which ended at least 8 weeks before the start of this study. * Washing phase of 15 days without application of products on the face, or oral intake. Exclusion Criteria: * People with gastrointestinal diseases (diabetes, gastritis, Crohn's disease, celiac disease, ulcers, intolerances, etc.). * People with allergies to 'purple basil' or its excipients (maltodextrin, magnesium stearate). * Have other physiological disorders (diabetes, hypertension, dyslipidemia) and/or gallstones. * Individuals under medical treatment in the weeks prior to the study, which may interfere with the evaluations of the present study. * People who are pregnant or intend to be pregnant within the study period, as well as people who are breastfeeding. * People who are within a dietary period outside of their usual habit, or intend to change their eating routine during the study period. * People participating in another clinical study with similar characteristics (according to the investigator's criteria), during the study period.
Where it's running
-
Dermaclaim Lab S.L.
Valencia, Valencia, Spain Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.